Pharmaco - Press Releases

Date	Title	Company
20-Nov-2023	“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential	Inizio
20-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
20-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
20-Nov-2023	Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference	Mainz BioMed N.V.
20-Nov-2023	Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052	Drägerwerk AG & Co. KGaA
20-Nov-2023	Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000	Tryp Therapeutics Inc.
20-Nov-2023	Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy	BRAIN Biotech AG
20-Nov-2023	Cantourage Group SE records significant revenue growth in the first nine months of 2023 and confirms full-year forecast	Cantourage Group SE
19-Nov-2023	Bayer Aktiengesellschaft: OCEANIC-AF study stopped early due to lack of efficacy	Bayer Aktiengesellschaft
17-Nov-2023	Biophytis announces receipt of Nasdaq Notice	Biophytis
17-Nov-2023	Almirall receives European Commission approval of EBGLYSS® (lebrikizumab) for moderate-to-severe atopic dermatitis	Almirall
17-Nov-2023	NICE recommends empagliflozin (Jardiance®) for the treatment of adults with chronic kidney disease	NICE
17-Nov-2023	‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements	UCB
17-Nov-2023	POLB 001 LPS Challenge Trial Data to be Presented at IUIS	Poolbeg Pharma plc
16-Nov-2023	Exciting Leadership Announcement: huumun welcomes James Karcher as Chief Commercial Officer	huumun
16-Nov-2023	Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Mainz BioMed N.V.
16-Nov-2023	M1 Kliniken AG publishes figures for the third quarter 2023: Further strong growth and doubling of the operating result	M1 Kliniken AG
16-Nov-2023	HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in	HAEMATO AG
15-Nov-2023	MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results	MorphoSys AG
15-Nov-2023	Termination of the botulinum toxin project	HAEMATO AG